Annual Total Liabilities
$33.61 B
-$1.75 B-4.94%
December 31, 2024
Summary
- As of February 7, 2025, TEVA annual total liabilities is $33.61 billion, with the most recent change of -$1.75 billion (-4.94%) on December 31, 2024.
- During the last 3 years, TEVA annual total liabilities has fallen by -$2.82 billion (-7.73%).
- TEVA annual total liabilities is now -42.12% below its all-time high of $58.06 billion, reached on December 31, 2016.
Performance
TEVA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$33.61 B
-$1.77 B-5.00%
December 31, 2024
Summary
- As of February 7, 2025, TEVA quarterly total liabilities is $33.61 billion, with the most recent change of -$1.77 billion (-5.00%) on December 31, 2024.
- Over the past year, TEVA quarterly total liabilities has dropped by -$1.62 billion (-4.61%).
- TEVA quarterly total liabilities is now -45.55% below its all-time high of $61.72 billion, reached on September 30, 2016.
Performance
TEVA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TEVA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.9% | -4.6% |
| 3 y3 years | -7.7% | -6.9% |
| 5 y5 years | -20.8% | -15.1% |
TEVA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.7% | at low | -8.7% | at low |
| 5 y | 5-year | -20.8% | at low | -20.8% | at low |
| alltime | all time | -42.1% | >+9999.0% | -45.5% | >+9999.0% |
Teva Pharmaceutical Industries Limited Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $33.61 B(-4.9%) | $33.61 B(-5.0%) |
| Sep 2024 | - | $35.37 B(+1.7%) |
| Jun 2024 | - | $34.77 B(-1.3%) |
| Mar 2024 | - | $35.23 B(-0.3%) |
| Dec 2023 | $35.35 B(-0.2%) | $35.35 B(+2.2%) |
| Sep 2023 | - | $34.58 B(-2.3%) |
| Jun 2023 | - | $35.39 B(+1.6%) |
| Mar 2023 | - | $34.84 B(-1.6%) |
| Dec 2022 | $35.41 B(-2.8%) | $35.41 B(+2.0%) |
| Sep 2022 | - | $34.73 B(-3.8%) |
| Jun 2022 | - | $36.10 B(-1.9%) |
| Mar 2022 | - | $36.80 B(+1.0%) |
| Dec 2021 | $36.42 B(-8.0%) | $36.42 B(+0.1%) |
| Sep 2021 | - | $36.40 B(-3.9%) |
| Jun 2021 | - | $37.88 B(-0.4%) |
| Mar 2021 | - | $38.03 B(-3.9%) |
| Dec 2020 | $39.58 B(-6.7%) | $39.58 B(+1.1%) |
| Sep 2020 | - | $39.15 B(-2.5%) |
| Jun 2020 | - | $40.17 B(-1.4%) |
| Mar 2020 | - | $40.74 B(-3.9%) |
| Dec 2019 | $42.41 B(-5.5%) | $42.41 B(+0.2%) |
| Sep 2019 | - | $42.32 B(-4.2%) |
| Jun 2019 | - | $44.17 B(+0.3%) |
| Mar 2019 | - | $44.03 B(-1.9%) |
| Dec 2018 | $44.89 B(-13.5%) | $44.89 B(-2.3%) |
| Sep 2018 | - | $45.93 B(-3.6%) |
| Jun 2018 | - | $47.66 B(-2.9%) |
| Mar 2018 | - | $49.08 B(-5.4%) |
| Dec 2017 | $51.87 B(-10.7%) | $51.87 B(-7.0%) |
| Sep 2017 | - | $55.79 B(-1.7%) |
| Jun 2017 | - | $56.75 B(+2.2%) |
| Mar 2017 | - | $55.53 B(-4.4%) |
| Dec 2016 | $58.06 B(+138.9%) | $58.06 B(-5.9%) |
| Sep 2016 | - | $61.72 B(+138.3%) |
| Jun 2016 | - | $25.90 B(+5.6%) |
| Mar 2016 | - | $24.54 B(+0.9%) |
| Dec 2015 | $24.31 B(+5.4%) | $24.31 B(-5.5%) |
| Sep 2015 | - | $25.73 B(-5.7%) |
| Jun 2015 | - | $27.29 B(+12.4%) |
| Mar 2015 | - | $24.27 B(+5.2%) |
| Dec 2014 | $23.07 B(-7.3%) | $23.07 B(+0.6%) |
| Sep 2014 | - | $22.94 B(-0.9%) |
| Jun 2014 | - | $23.14 B(-3.0%) |
| Mar 2014 | - | $23.86 B(-4.1%) |
| Dec 2013 | $24.87 B(-10.3%) | $24.87 B(-2.3%) |
| Sep 2013 | - | $25.46 B(-1.7%) |
| Jun 2013 | - | $25.89 B(+2.5%) |
| Mar 2013 | - | $25.25 B(-9.0%) |
| Dec 2012 | $27.74 B(-0.2%) | $27.74 B(+4.7%) |
| Sep 2012 | - | $26.51 B(+2.0%) |
| Jun 2012 | - | $25.99 B(-4.7%) |
| Mar 2012 | - | $27.27 B(-1.9%) |
| Dec 2011 | $27.80 B(+72.1%) | $27.80 B(+51.6%) |
| Sep 2011 | - | $18.34 B(+11.8%) |
| Jun 2011 | - | $16.41 B(+1.8%) |
| Mar 2011 | - | $16.12 B(-0.2%) |
| Dec 2010 | $16.15 B(+15.8%) | $16.15 B(-6.8%) |
| Sep 2010 | - | $17.33 B(+9.5%) |
| Jun 2010 | - | $15.82 B(+10.1%) |
| Mar 2010 | - | $14.37 B(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $13.95 B(-15.7%) | $13.95 B(-0.3%) |
| Sep 2009 | - | $13.99 B(-2.8%) |
| Jun 2009 | - | $14.40 B(-10.6%) |
| Mar 2009 | - | $16.11 B(-2.6%) |
| Dec 2008 | $16.54 B(+71.4%) | $16.54 B(+64.0%) |
| Sep 2008 | - | $10.09 B(+1.9%) |
| Jun 2008 | - | $9.90 B(-2.9%) |
| Mar 2008 | - | $10.20 B(+5.7%) |
| Dec 2007 | $9.65 B(+3.9%) | $9.65 B(+1.2%) |
| Sep 2007 | - | $9.54 B(-1.2%) |
| Jun 2007 | - | $9.65 B(+0.5%) |
| Mar 2007 | - | $9.60 B(+3.3%) |
| Dec 2006 | $9.29 B(+114.3%) | $9.29 B(-1.0%) |
| Sep 2006 | - | $9.39 B(-0.4%) |
| Jun 2006 | - | $9.43 B(+3.4%) |
| Mar 2006 | - | $9.12 B(+110.4%) |
| Dec 2005 | $4.34 B(+2.5%) | $4.34 B(+6.1%) |
| Sep 2005 | - | $4.09 B(-0.6%) |
| Jun 2005 | - | $4.12 B(-2.2%) |
| Mar 2005 | - | $4.21 B(-0.6%) |
| Dec 2004 | $4.23 B(+61.5%) | $4.23 B(+6.0%) |
| Sep 2004 | - | $3.99 B(-6.3%) |
| Jun 2004 | - | $4.26 B(+0.0%) |
| Mar 2004 | - | $4.26 B(+62.6%) |
| Dec 2003 | $2.62 B(-6.2%) | $2.62 B(-13.6%) |
| Sep 2003 | - | $3.03 B(+0.3%) |
| Jun 2003 | - | $3.02 B(+4.7%) |
| Mar 2003 | - | $2.89 B(+3.4%) |
| Dec 2002 | $2.79 B(+34.4%) | $2.79 B(+24.6%) |
| Sep 2002 | - | $2.24 B(+1.9%) |
| Jun 2002 | - | $2.20 B(+6.6%) |
| Mar 2002 | - | $2.06 B(-0.6%) |
| Dec 2001 | $2.08 B(+22.0%) | $2.08 B(+0.2%) |
| Sep 2001 | - | $2.07 B(+30.2%) |
| Jun 2001 | - | $1.59 B(-1.8%) |
| Mar 2001 | - | $1.62 B(-4.8%) |
| Dec 2000 | $1.70 B(+68.9%) | $1.70 B(+34.0%) |
| Sep 2000 | - | $1.27 B(-2.7%) |
| Jun 2000 | - | $1.31 B(+34.4%) |
| Mar 2000 | - | $971.20 M(-3.7%) |
| Dec 1999 | $1.01 B(+29.8%) | $1.01 B(-2.8%) |
| Sep 1999 | - | $1.04 B(+40.4%) |
| Jun 1999 | - | $739.10 M(-0.8%) |
| Mar 1999 | - | $744.80 M(-4.1%) |
| Dec 1998 | $776.40 M(+34.9%) | $776.40 M(+2.3%) |
| Sep 1998 | - | $759.20 M(+18.1%) |
| Jun 1998 | - | $643.00 M(+19.4%) |
| Mar 1998 | - | $538.50 M(-6.4%) |
| Dec 1997 | $575.60 M(-18.5%) | $575.60 M(-18.5%) |
| Dec 1996 | $706.20 M(+27.9%) | $706.20 M(+27.9%) |
| Dec 1995 | $552.20 M(+65.5%) | $552.20 M(+65.5%) |
| Dec 1994 | $333.60 M(+13.0%) | $333.60 M(+13.0%) |
| Dec 1993 | $295.10 M(+33.0%) | $295.10 M(+33.0%) |
| Dec 1992 | $221.90 M(+14.6%) | $221.90 M(+14.6%) |
| Dec 1991 | $193.70 M(-7.0%) | $193.70 M(-7.0%) |
| Dec 1990 | $208.20 M(+24.4%) | $208.20 M(+24.4%) |
| Dec 1989 | $167.30 M(+12.3%) | $167.30 M(+12.3%) |
| Dec 1988 | $149.00 M(+75.3%) | $149.00 M(+75.3%) |
| Mar 1987 | $85.00 M(-4.7%) | $85.00 M(-4.7%) |
| Mar 1986 | $89.20 M | $89.20 M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual total liabilities?
- What is the all time high annual total liabilities for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual total liabilities year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly total liabilities?
- What is the all time high quarterly total liabilities for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly total liabilities year-on-year change?
What is Teva Pharmaceutical Industries Limited annual total liabilities?
The current annual total liabilities of TEVA is $33.61 B
What is the all time high annual total liabilities for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual total liabilities is $58.06 B
What is Teva Pharmaceutical Industries Limited annual total liabilities year-on-year change?
Over the past year, TEVA annual total liabilities has changed by -$1.75 B (-4.94%)
What is Teva Pharmaceutical Industries Limited quarterly total liabilities?
The current quarterly total liabilities of TEVA is $33.61 B
What is the all time high quarterly total liabilities for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly total liabilities is $61.72 B
What is Teva Pharmaceutical Industries Limited quarterly total liabilities year-on-year change?
Over the past year, TEVA quarterly total liabilities has changed by -$1.62 B (-4.61%)